Report error Found 73 Enz. Inhib. hit(s) with all data for entry = 50034049
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 5nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetMast/stem cell growth factor receptor Kit(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 9nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 39nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 42nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 56nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 58nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 61nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 72nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 81nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 83nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 122nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 192nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 283nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 310nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 490nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 530nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 650nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 960nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetMast/stem cell growth factor receptor Kit(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.11E+3nMAssay Description:Inhibition of cKITMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 2.80E+3nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-3(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 3.30E+3nMAssay Description:Inhibition of PIM3 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 4.76E+3nMAssay Description:Inhibition of KDRMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-1(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 4.90E+3nMAssay Description:Inhibition of PIM1 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Novartis Institutes of Biomedical Research
Curated by ChEMBL
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of PIM2 using BAD peptide as substrate preincubated for 15 mins measured after 60 to 100 mins by luminescence assayMore data for this Ligand-Target Pair